Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/12/26
Moderna's Revenues See Strong International Momentum in Q1 EarningsZacks Investment Research • 05/12/26
Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.Investopedia • 05/12/26
Here's how much Moderna's stock has rallied off renewed focus on hantavirus researchMarket Watch • 05/11/26
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?24/7 Wall Street • 05/11/26
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010Accesswire • 05/06/26
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era24/7 Wall Street • 05/04/26
Moderna Reports Q1 Loss, Stock Jumps on Strong International SalesZacks Investment Research • 05/01/26
Moderna reports mixed Q1 results as revenue beats estimates but litigation charge weighs on earningsProactive Investors • 05/01/26
Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives OutlookSeeking Alpha • 05/01/26
Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.Barrons • 05/01/26